Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 1
1948 3
1952 1
1953 2
1954 3
1955 3
1957 1
1958 3
1959 11
1960 3
1961 4
1962 4
1963 9
1964 6
1965 5
1966 3
1967 8
1968 8
1969 9
1970 14
1971 10
1972 13
1973 10
1974 17
1975 16
1976 16
1977 14
1978 23
1979 23
1980 25
1981 41
1982 45
1983 33
1984 54
1985 56
1986 66
1987 69
1988 87
1989 86
1990 102
1991 142
1992 164
1993 200
1994 185
1995 209
1996 192
1997 270
1998 255
1999 304
2000 326
2001 329
2002 416
2003 442
2004 634
2005 701
2006 868
2007 957
2008 1100
2009 1360
2010 1559
2011 1849
2012 2122
2013 2421
2014 2827
2015 3200
2016 3359
2017 3637
2018 4004
2019 4588
2020 5492
2021 5972
2022 6989
2023 7141
2024 3103

Text availability

Article attribute

Article type

Publication date

Search Results

60,858 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Qun-nan
Page 1
2021 update on thyroid-associated ophthalmopathy.
Neag EJ, Smith TJ. Neag EJ, et al. J Endocrinol Invest. 2022 Feb;45(2):235-259. doi: 10.1007/s40618-021-01663-9. Epub 2021 Aug 20. J Endocrinol Invest. 2022. PMID: 34417736 Free PMC article. Review.
PURPOSE: Our understanding of thyroid-associated ophthalmopathy (TAO, A.K.A Graves' orbitopathy, thyroid eye disease) has advanced substantially, since one of us (TJS) wrote the 2010 update on TAO, appearing in this journal. ...A clearer understanding of autoimmune …
PURPOSE: Our understanding of thyroid-associated ophthalmopathy (TAO, A.K.A Graves' orbitopathy, thyroid eye disease) has advanced su …
Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy.
Li Z, Wang M, Tan J, Zhu L, Zeng P, Chen X, Xie L, Duan R, Chen B, Tao T, Wang R, Wang X, Su W. Li Z, et al. Cell Rep Med. 2022 Aug 16;3(8):100699. doi: 10.1016/j.xcrm.2022.100699. Epub 2022 Jul 26. Cell Rep Med. 2022. PMID: 35896115 Free PMC article.
ACKR1(+) endothelial cells and adipose tissue macrophages may engage in TAO pathogenesis. We find CD8(+)CD57(+) cytotoxic T lymphocytes with the terminal differentiation phenotype to be another source of interferon-gamma, a molecule actively engaging in TAO pathogen …
ACKR1(+) endothelial cells and adipose tissue macrophages may engage in TAO pathogenesis. We find CD8(+)CD57(+) cytotoxic T lymphocyt …
Cannabis-associated arteritis.
Grotenhermen F. Grotenhermen F. Vasa. 2010 Feb;39(1):43-53. doi: 10.1024/0301-1526/a000004. Vasa. 2010. PMID: 20186675 Review.
Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. ...CONCLUSIONS: The hypothesis of cannabis being a causative factor or co-fac …
Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, t …
Traditional Chinese medicine in thyroid-associated orbitopathy.
Hai YP, Lee ACH, Chen K, Kahaly GJ. Hai YP, et al. J Endocrinol Invest. 2023 Jun;46(6):1103-1113. doi: 10.1007/s40618-023-02024-4. Epub 2023 Feb 12. J Endocrinol Invest. 2023. PMID: 36781592 Free PMC article. Review.
METHODS: The pertinent and current literature of pre-clinical studies on TAO investigating the effects of active ingredients of TCM was reviewed using the NCBI PubMed database. RESULTS: Eleven TCM compounds demonstrated inhibition of TAO-OF in-vitro and three of the …
METHODS: The pertinent and current literature of pre-clinical studies on TAO investigating the effects of active ingredients of TCM w …
Cytokines in Thyroid-Associated Ophthalmopathy.
Zhang P, Zhu H. Zhang P, et al. J Immunol Res. 2022 Nov 14;2022:2528046. doi: 10.1155/2022/2528046. eCollection 2022. J Immunol Res. 2022. PMID: 36419958 Free PMC article. Review.
Thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' orbitopathy (GO), is a complex autoimmune condition causing visual impairment, disfigurement, and harm to patients' physical and mental health. ...In this review, we summarize the r …
Thyroid-associated ophthalmopathy (TAO), also known as thyroid eye disease (TED) or Graves' orbitopathy (GO), is a complex autoimmune …
Development and application of animal models to study thyroid-associated ophthalmopathy.
Shen F, Liu J, Fang L, Fang Y, Zhou H. Shen F, et al. Exp Eye Res. 2023 May;230:109436. doi: 10.1016/j.exer.2023.109436. Epub 2023 Mar 11. Exp Eye Res. 2023. PMID: 36914000 Review.
Thyroid-associated ophthalmopathy (TAO), also known as Graves' ophthalmopathy, is an autoimmune disease that is usually accompanied by hyperthyroidism. ...The thyroid-stimulating hormone receptor (TSHR) is known to play an important role in the development of TAO. B …
Thyroid-associated ophthalmopathy (TAO), also known as Graves' ophthalmopathy, is an autoimmune disease that is usually accompanied b …
Epigenetics effect on pathogenesis of thyroid-associated ophthalmopathy.
Cao JM, Wang N, Hou SY, Qi X, Xiong W. Cao JM, et al. Int J Ophthalmol. 2021 Sep 18;14(9):1441-1448. doi: 10.18240/ijo.2021.09.22. eCollection 2021. Int J Ophthalmol. 2021. PMID: 34540623 Free PMC article. Review.
Thyroid-associated ophthalmopathy (TAO) is an autoimmune disease. Recent studies have found the aberrant epigenetics in TAO, including DNA methylation, non-coding RNAs, and histone modification. ...The quantities of H4 in TAO are increased compared with euthy …
Thyroid-associated ophthalmopathy (TAO) is an autoimmune disease. Recent studies have found the aberrant epigenetics in TAO, i …
Thyroid-associated orbitopathy.
Alsuhaibani AH, Nerad JA. Alsuhaibani AH, et al. Semin Plast Surg. 2007 Feb;21(1):65-73. doi: 10.1055/s-2007-967751. Semin Plast Surg. 2007. PMID: 20567660 Free PMC article.
Thyroid-associated orbitopathy (TAO) is usually diagnosed clinically. Early presentation of TAO such as ocular irritation, lid puffiness, and mild retraction may be overlooked and misdiagnosed. ...Surgery remains the final rehabilitation in TAO, which should …
Thyroid-associated orbitopathy (TAO) is usually diagnosed clinically. Early presentation of TAO such as ocular irritation, lid …
Real-Time Extension of TAO-DFT.
Tsai HY, Chai JD. Tsai HY, et al. Molecules. 2023 Oct 24;28(21):7247. doi: 10.3390/molecules28217247. Molecules. 2023. PMID: 37959667 Free PMC article.
To explore the time-dependent (TD) properties of electronic systems (e.g., subject to an intense laser pulse), in this work, we propose a real-time (RT) extension of TAO-DFT, denoted as RT-TAO-DFT. Moreover, we employ RT-TAO-DFT to study the high-order harmon …
To explore the time-dependent (TD) properties of electronic systems (e.g., subject to an intense laser pulse), in this work, we propose a re …
Fibrocyte Participation in Thyroid-Associated Ophthalmopathy Suggests New Approaches to Therapy.
Smith TJ. Smith TJ. Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S9-S18. doi: 10.1097/IOP.0000000000002509. Epub 2023 Dec 4. Ophthalmic Plast Reconstr Surg. 2023. PMID: 38054981 Review.
PURPOSE: Review the historical context of research and changing therapeutic landscape of thyroid-associated ophthalmopathy (TAO) by focusing on the relationship between TAO, CD34+ fibrocytes, thyrotropin receptor (TSHR), and insulin-like growth factor-I receptor (IG …
PURPOSE: Review the historical context of research and changing therapeutic landscape of thyroid-associated ophthalmopathy (TAO) by f …
60,858 results
You have reached the last available page of results. Please see the User Guide for more information.